GlassScriptPhysician profile
Michael R Jones
NPI 1942244413
$3,077.82
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $488 · 2021: $1,901 · 2022: $22.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentuity, LLC | $1,578.95 | 2021 | |
| Abbott Laboratories | $291.21 | 2019-2022 | |
| Boston Scientific Corporation | $194.76 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $148.02 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.85 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $115.28 | 2019 | |
| Orthofix Medical, INC. | $111.14 | 2020 | |
| Amgen INC. | $90.00 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $61.36 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $53.37 | 2020-2021 | |
| Alk-Abello, INC | $49.06 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $41.08 | 2019 | |
| Pfizer INC. | $38.82 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $38.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.36 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $31.53 | 2021 | |
| Lundbeck LLC | $22.97 | 2019-2021 | |
| Akcea Therapeutics, INC. | $14.54 | 2020 | |
| Medtronic Vascular, INC. | $11.54 | 2019 | |
| Amarin Pharma, INC. | $11.11 | 2020 | |
| Esperion Therapeutics, INC. | $11.08 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.